Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
Cell Death and Differentiation
|
September 5, 2018
Correction: Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells
Daniela Kramer, Nadine Stark, Ramona Schulz-Heddergott, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
December 28, 2016
L1CAM in the Early Enteric and Urogenital System
Elisabeth Judith Pechriggl, Nicole Concin, Michael J Blumer, et al.
Contraception
|
March 10, 2012
Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system
Beata Seeber, Stephanie C Ziehr, Andreas Gschlieβer, et al.
International Journal of Cancer
|
January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer
Alain G Zeimet, Daniel Reimer, Dominik Wolf, et al.
Cancer Immunology, Immunotherapy : CII
|
August 19, 2010
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer
Alain G Zeimet, Daniel Reimer, Lukas Schwentner, et al.
ESMO Open
|
November 26, 2020
Implementing clinical practice guidelines: time to assess it
Cristiana Sessa, Nicoletta Colombo, Carien L Creutzberg, et al.
Obstetrics and Gynecology
|
May 24, 2012
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer
Stephan Polterauer, Susan Khalil, Oliver Zivanovic, et al.
Cancers
|
April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
Rafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 15, 2020
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development
Nicole Concin, Isabelle Ray-Coquard, Rosalind M Glasspool, et al.
Cancer Research
|
April 3, 2004
Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo
Nicole Concin, Kirsten Becker, Neda Slade, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
Cell Death and Differentiation
|
September 5, 2018
Correction: Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells
Daniela Kramer, Nadine Stark, Ramona Schulz-Heddergott, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
December 28, 2016
L1CAM in the Early Enteric and Urogenital System
Elisabeth Judith Pechriggl, Nicole Concin, Michael J Blumer, et al.
Contraception
|
March 10, 2012
Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system
Beata Seeber, Stephanie C Ziehr, Andreas Gschlieβer, et al.
International Journal of Cancer
|
January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer
Alain G Zeimet, Daniel Reimer, Dominik Wolf, et al.
Cancer Immunology, Immunotherapy : CII
|
August 19, 2010
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer
Alain G Zeimet, Daniel Reimer, Lukas Schwentner, et al.
ESMO Open
|
November 26, 2020
Implementing clinical practice guidelines: time to assess it
Cristiana Sessa, Nicoletta Colombo, Carien L Creutzberg, et al.
Obstetrics and Gynecology
|
May 24, 2012
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer
Stephan Polterauer, Susan Khalil, Oliver Zivanovic, et al.
Cancers
|
April 12, 2022
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
Rafał Watrowski, Eva Obermayr, Christine Wallisch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 15, 2020
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development
Nicole Concin, Isabelle Ray-Coquard, Rosalind M Glasspool, et al.
Cancer Research
|
April 3, 2004
Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo
Nicole Concin, Kirsten Becker, Neda Slade, et al.
Page
of 14